Page last updated: 2024-09-05

glucovance and Hyperglycemia, Postprandial

glucovance has been researched along with Hyperglycemia, Postprandial in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abrahamson, MJ	1
Blonde, L; Henry, D; Howlett, H; Joyal, S	1
Davidson, JA; Howlett, HC; Scheen, AJ	1

Reviews

1 review(s) available for glucovance and Hyperglycemia, Postprandial

Article	Year
Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus. Drug safety, 2004, Volume: 27, Issue:15 Topics: Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Glyburide; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Lipids; Metformin; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Tablets; Time Factors; Treatment Outcome	2004

Article

Year

Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus.

Drug safety, 2004, Volume: 27, Issue:15

Topics: Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Glyburide; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Lipids; Metformin; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Tablets; Time Factors; Treatment Outcome

2004

Trials

1 trial(s) available for glucovance and Hyperglycemia, Postprandial

Article	Year
Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy. International journal of clinical practice, 2004, Volume: 58, Issue:9 Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Tablets; Treatment Outcome	2004

Article

Year

Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.

International journal of clinical practice, 2004, Volume: 58, Issue:9

Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Tablets; Treatment Outcome

2004

Other Studies

1 other study(ies) available for glucovance and Hyperglycemia, Postprandial

Article	Year
Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. Archives of internal medicine, 2004, Mar-08, Volume: 164, Issue:5 Topics: Antihypertensive Agents; Blood Glucose; Blood Glucose Self-Monitoring; Carbamates; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Drug Therapy, Combination; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Metformin; Piperidines; Postprandial Period	2004

Article

Year

Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.

Archives of internal medicine, 2004, Mar-08, Volume: 164, Issue:5

Topics: Antihypertensive Agents; Blood Glucose; Blood Glucose Self-Monitoring; Carbamates; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Drug Therapy, Combination; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Metformin; Piperidines; Postprandial Period

2004